Search - tctmd.com

Displaying 381 - 400 of 1206

Sort: Relevancy | Date

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Todd Neale

July 16, 2018

Podcast TCTMD Talking Points

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

June 20, 2018

News Industry News

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

June 18, 2018

News Conference News EuroPCR 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Caitlin E. Cox

May 30, 2018

News Conference News EuroPCR 2018

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Caitlin E. Cox

May 25, 2018

News Conference News EuroPCR 2018

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Shelley Wood

May 24, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

Podcast TCTMD Talking Points

MITRAL: 30-Day Outcomes of Transcatheter MV Replacement in Severe MV Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

May 16, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Stent Failures -Identifying Causes of Stent Thrombosis and Restenosis and How to Fix It

Presenter: Ron Waksman

May 05, 2018

News Industry News

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

April 24, 2018

News Daily News

Uncomplicated TLR After PCI Linked With Worse Mortality

Michael O'Riordan

April 20, 2018

Presentation SCAI 2018

How to treat: Recurrent In-stent Restenosis

Presenter: Kenneth Chin

March 23, 2018

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Caitlin E. Cox

March 19, 2018

News Daily News

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

Yael L. Maxwell

February 26, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Conference News ISET 2018

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

Caitlin E. Cox

February 08, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

Presentation CHIP Florida 2018

In-stent Restenosis Due to Underexpanded Stent

Presenter: Nirat Beohar

January 22, 2018

Presentation CHIP Florida 2018

Recalcitrant In-stent Restenosis

Presenter: Jeffrey W. Moses

January 19, 2018

Advertisement

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

MITRAL: 30-Day Outcomes of Transcatheter MV Replacement in Severe MV Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

Stent Failures -Identifying Causes of Stent Thrombosis and Restenosis and How to Fix It

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

Uncomplicated TLR After PCI Linked With Worse Mortality

How to treat: Recurrent In-stent Restenosis

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

SELUTION™ First-in-Man Study Achieves Primary Endpoint

In-stent Restenosis Due to Underexpanded Stent

Recalcitrant In-stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content